Huiru Cui

Dr. Huiru Cui


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 March 2020 in Depression and Anxiety
Verified
Journal Article
Closed access
PDF file
HCHuiru Cui
Huiru Cui
BZBin Zhang
Bin Zhang
WLWei Li
Wei Li
HLHui Li
Hui Li
JPJiaoyan Pang
Jiaoyan Pang
GNGeorg Northoff
Georg Northoff

1 October 2021 in Schizophrenia Research
Verified
Journal Article
Closed access
YWYingchan Wang
Yingchan Wang
YJYuchao Jiang
Yuchao Jiang
GCGuusje Collin
Guusje Collin
DLDengtang Liu
Dengtang Liu
WSWenjun Su
Wenjun Su
JWJijun Wang
Jijun Wang

12 October 2020 in Pharmacopsychiatry
Verified
Journal Article
Closed access
PDF file
TZTianHong Zhang
TianHong Zhang
JWJunJie Wang
JunJie Wang
LXLiHua Xu
LiHua Xu
YWYanYan Wei
YanYan Wei
XTXiaoChen Tang
XiaoChen Tang
JWJijun Wang
Jijun Wang
Introduction In a previous report, we used canonical correlation analysis to classify individuals with clinical high risk (CHR) of psychosis into the 3 subtypes: subtype-1, characterized by extensive negative symptoms and cognitive deficits, appeared to have the highest risk for conversion to psychosis; subtype-2, characterized by thought and behavioral disorganization, with moderate cognitive impairment; subtype-3, characterized by the mildest symptoms and cognitive deficits. The present study attempted to identify these subtypes’ response to antipsychotic (AP) treatment. Methods A total of 289 individuals with CHR were identified and followed up for 2 years. Individuals with CHR were classified by subtype. Use of APs was examined at 2-month, 1-year, and 2-year follow-up interviews that inquired after the subjects’ medication history since the first visit. The main outcome was remission, determined according to global assessment of function (GAF) score (i. e., functional outcome) and SIPS positive symptom score (symptomatic outcome) at the follow-up points. Results Among the 289 individuals with CHR included in the current analysis, 223 (77.2%) were treated using APs for at least 2 weeks during the follow-up period. Individuals with CHR tended to show significant improvement in both symptoms and function after 2 years, but subtypes exhibited significantly different trajectories. Subtype status can predict AP treatment outcome in terms of remission. The likelihood of remission differed significantly among the subtype groups. The remission rates for individuals with subtypes 1–3 treated using AP were 13.5%, 36.1%, and 67.0%, respectively. Discussion These subtypes may be of clinical value in AP treatment decision-making in the CHR population. + The author shares first authorship. Received: 06 July 2020 Received: 20 August 2020 Accepted: 21 August 2020 Article published online: 12 October 2020 © 2020. Thieme. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany

11 September 2025 in Behavioral Sciences
Verified
Journal Article
Open access
PDF file
LSLetao Sun
Letao Sun
HZHaochen Zou
Haochen Zou
WLWei Li
Wei Li
HLHui Li
Hui Li
JPJiaoyan Pang
Jiaoyan Pang
CLChunbo Li
Chunbo Li
To explore the correlation of intolerance of uncertainty (IU) and emotion regulation (ER) in patients with generalized anxiety disorder (GAD), a total of 108 GAD patients and 115 healthy participants were recruited. The intolerance of uncertainty scale (IUS) was used to evaluate the level of IU. The emotion regulation questionnaire (ERQ) was used to evaluate participants’ preference for emotion regulation strategies. The Hamilton anxiety scale (HAMA) and generalized anxiety disorder scale (GAD-7) were used to assess the degree of anxiety symptoms. Spearman correlation analysis and linear regression analysis were performed on participants’ scores. The scores of the IUS subscales, ERQ subscales, and HAMA in the GAD group were different from those in healthy controls (HC group) (p ≤ 0.001). IUS subscales were correlated with ERQ subscales, and inhibitory IU was significantly correlated with expression suppression strategies (p < 0.01). The level of IU is correlated with the selection of emotion regulation strategies in patients with GAD. Moderating effect analysis shows that emotion regulation strategies partially moderate the relationship between IU level and anxiety symptoms. This study underscores the critical role of intolerance of uncertainty and emotion regulation in shaping anxiety severity in GAD, highlighting the potential for targeted interventions that address both cognitive and emotional dimensions.

19 June 2025 in Neuroscience Bulletin
Verified
Journal Article
Closed access
PDF file
HCHuiru Cui
Huiru Cui
JWJijun Wang
Jijun Wang
CLChunbo Li
Chunbo Li

27 April 2026 in The British Journal of Psychiatry
Verified
Journal Article
Closed access
PDF file
DZDan Zhang
Dan Zhang
YLYu Li
Yu Li
LXLihua Xu
Lihua Xu
YXYangyang Xu
Yangyang Xu
XLXu Liu
Xu Liu
JWJijun Wang
Jijun Wang
Background: Anxiety disorders are highly prevalent yet lack objective biomarkers. Whereas threat-related attentional biases are well documented, less is known about broader eye movement alterations that may characterise anxiety. Aims: To characterise multi-paradigm eye movement profiles in anxiety disorders and evaluate their potential as behavioural markers for disorder differentiation. Method: Eye movements were recorded in 91 patients with anxiety disorders, 118 with depressive disorders and 98 healthy controls during free viewing of neutral-stimuli, smooth-pursuit and fixation-stability tasks. Principal component analysis was applied to derive latent eye movement dimensions, which were then tested for group differences, associations with symptom severity and classification performance. Results: Compared with both patients with depression and healthy controls, patients with anxiety disorders exhibited hyper-scanning during free viewing, characterised by increased saccade frequency and path length, and hyper-pursuit during smooth pursuit, reflected in increased velocity gain, fewer intrusive saccades and more catch-up saccades. Principal component analysis identified six latent components, among which active visual exploration, pupillary arousal and smooth-pursuit control demonstrated robust group differences. Machine learning models trained on 6 components yielded areas under the receiver operating characteristic curve of 0.82 for anxiety versus healthy controls, 0.83 for depression versus healthy controls and 0.61 for anxiety versus depression. Conclusions: Hyper-scanning and hyper-pursuit emerge as defining eye movement signatures of anxiety, linking core mechanisms of vigilance and prediction with measurable behavioural markers. These insights position eye-tracking as a promising behavioural modality for mechanism-informed differentiation across affective disorders.